Author:
Schubert T, Schaaf CP.
Scientific Notation:
Dev Med Child Neurol. 2025 Jan;67(1):35-48. doi: 10.1111/dmcn.16018. Epub 2024 Jul 1. PMID: 38950199; PMCID: PMC11625468.
Publication Link:
https://pmc.ncbi.nlm.nih.gov/articles/PMC11625468/
Schubert T, Schaaf CP.
Dev Med Child Neurol. 2025 Jan;67(1):35-48. doi: 10.1111/dmcn.16018. Epub 2024 Jul 1. PMID: 38950199; PMCID: PMC11625468.
https://pmc.ncbi.nlm.nih.gov/articles/PMC11625468/
Schaaf–Yang syndrome (SYS) is a complex neurodevelopmental disorder characterized by autism spectrum disorder, joint contractures, and profound hypothalamic dysfunction. SYS is caused by variants in MAGEL2, a gene within the Prader–Willi syndrome (PWS) locus on chromosome 15. In this review, we consolidate decades of research on MAGEL2 to elucidate its physiological functions. Moreover, we synthesize current knowledge on SYS, suggesting that while MAGEL2 loss‐of‐function seems to underlie several SYS and PWS phenotypes, additional pathomechanisms probably contribute to the distinct and severe phenotype observed in SYS. In addition, we highlight recent therapeutic advances and identify promising avenues for future investigation.
The Foundation for Prader-Willi Research (federal tax id 31-1763110) is a nonprofit corporation with federal tax exempt status as a public charity under section 501(c)(3).



The mission of FPWR is to eliminate the challenges of Prader-Willi syndrome through the advancement of research and therapeutic development.
Copyright © 2020. All Rights Reserved. Terms of Use. Privacy Policy. Copyright Infringement Policy. Disclosure Statement.